NVIDIA's BioNeMo team, working with the University of Washington's Institute for Protein Design, has introduced RFD4-Proteina, a model that generates both a protein's sequence and its full atomic structure in a single pass instead of handing off to a separate inverse-folding tool. By working with a residue-level representation and a streamlined diffusion process, the model needs only about 60 denoising steps instead of roughly 400, which translates into markedly quicker runs and a much smaller memory footprint than its predecessor RFD3 when generating a 200-residue protein. During generation, the model can also run a reward-guided search that scores and branches partial designs using GPU-accelerated evaluation tools such as OpenFold3 and TMol, steering computation toward the most promising candidates. It ships both as an open-source model on GitHub and as a NIM microservice reachable over HTTP, with toolkit skills available to let automated agents chain generation, scoring and evaluation steps together.
Google Research describes new work on grounding AI agents in physical lab reality, using a digital-twin framework called VERID to let agents safely plan and execute liquid-handling robot protocols. Combined with closed-loop molecular design cycles for aptamers and proteins, the agents iteratively learned from wet-lab results, improving hit rates over multiple rounds and discovering single-digit nanomolar protein binders for a cancer-related target.
Google DeepMind demonstrated how its agentic platform Google Antigravity, combined with the ProtNLM model, helped researchers search millions of uncharacterized proteins in UniProt to find a novel antimicrobial peptide candidate against respiratory pathogens. The AI agent handled database queries, structural comparison via AlphaFold, and genomic context analysis, while a human researcher guided the scientific strategy. The resulting candidate is now undergoing wet-lab validation, and DeepMind introduced a new 3D Biomolecular Structure Viewer built into Antigravity for shared human-agent inspection of protein structures.
Microsoft Research has unveiled Quine, a research system combining a multimodal 'world model' of biology with an interactive harness linking AI models, scientific literature, lab tools, and researchers. Built jointly across data types such as genomics, proteins, chemistry, RNA/cell state, and bioimaging, the model aims to predict how biological systems respond to interventions before costly lab experiments are run. Working with the Broad Institute of MIT and Harvard, Microsoft used Quine to rank thousands of compounds for their potential to shift pancreatic cancer cells between therapeutic states, and the top-ranked candidates were validated in wet-lab assays within a single weekend. Microsoft is now opening a 'Quine Fellows' program to give selected scientists early access, while cautioning that the system is experimental, research-only, and not intended for clinical use.